O-Veratraldehyde

O-Veratraldehyde

SCHEMBL29923149

COc1cccc(C=O)c1OC

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 1/20 0.67
▸ TLR2 O60603 1/20 0.63
▸ ERN1 O75460 1/20 0.63
▸ TLR1 Q15399 1/20 0.63
▸ TLR6 Q9Y2C9 1/20 0.63
▸ CA1 P00915 1/20 0.63
▸ CA2 P00918 1/20 0.63
▸ NFE2L2 Q16236 7/20 0.61
▸ PRMT1 Q99873 1/20 0.57
▸ KDM4E B2RXH2 2/20 0.54
▸ LMNA P02545 1/20 0.54
▸ HPGD P15428 1/20 0.54
▸ CYP1A1 P04798 3/20 0.53
▸ CYP1A2 P05177 3/20 0.53
▸ CYP1B1 Q16678 3/20 0.53
▸ CYP19A1 P11511 1/20 0.53
▸ MAPT P10636 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
O-Veratraldehyde SCHEMBL319070 1.00 SRC (0.67) SRCTLR2ERN1TLR1TLR6
O-Veratraldehyde SCHEMBL28289918 1.00 SRC (0.67) SRCTLR2ERN1TLR1TLR6
O-Veratraldehyde SCHEMBL28143507 0.93 SRC (0.64) SRCTLR2ERN1TLR1TLR6
O-Veratraldehyde SCHEMBL8706125 0.93 SRC (0.59) SRCTLR2ERN1TLR1TLR6
O-Veratraldehyde SCHEMBL28285734 0.91 SRC (0.58) SRCTLR2ERN1TLR1TLR6
SCHEMBL10434914 0.90 SRC (0.65) SRCTLR2ERN1TLR1TLR6
O-Veratraldehyde SCHEMBL27796936 0.89 SRC (0.56) SRCTLR2ERN1TLR1TLR6
O-Veratraldehyde SCHEMBL28388608 0.89 SRC (0.56) SRCTLR2ERN1TLR1TLR6
SCHEMBL2787203 0.87 CA1 (0.73) SRCTLR2ERN1TLR1TLR6
SCHEMBL11039664 0.86 SRC (0.61) SRCTLR2ERN1TLR1TLR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11591305-B2 Method for producing fisetin or fisetin derivatives DAEGU CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2023-02-28 — — US disclosed
US-20220220088-A1 METHOD FOR PRODUCING FISETIN OR FISETIN DERIVATIVES DAEGU CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2022-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220220088-A1 METHOD FOR PRODUCING FISETIN OR FISETIN DERIVATIVES FIS1, DNM2, SIRT5 SRC 4650/4885TLR2 4484/4885ERN1 3731/4885
US-11591305-B2 Method for producing fisetin or fisetin derivatives FIS1, DNM2, SIRT5 SRC 4650/4885TLR2 4484/4885ERN1 3731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback